{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T14:31:20Z","timestamp":1790519480864,"version":"4.1.0"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":1106,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["ZIA SC000550"],"award-info":[{"award-number":["ZIA SC000550"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1038\/s41379-019-0385-7","type":"journal-article","created":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T15:20:09Z","timestamp":1572016809000},"page":"96-106","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"S1","title":["Navigating the cutaneous B-cell lymphomas: avoiding the rocky shoals"],"prefix":"10.1016","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4632-0301","authenticated-orcid":false,"given":"Elaine S.","family":"Jaffe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/s41379-019-0385-7_bib1","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":"WHO-EORTC classification for cutaneous lymphomas","volume":"105","author":"Willemze","year":"2005","journal-title":"Blood"},{"key":"10.1038\/s41379-019-0385-7_bib2","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"Swerdlow","year":"2017"},{"key":"10.1038\/s41379-019-0385-7_bib3","series-title":"WHO classification of skin tumours","author":"Elder","year":"2018"},{"key":"10.1038\/s41379-019-0385-7_bib4","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1182\/blood-2018-11-881268","article-title":"The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas","volume":"133","author":"Willemze","year":"2019","journal-title":"Blood"},{"key":"10.1038\/s41379-019-0385-7_bib5","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/DAD.0b013e318289b20e","article-title":"Cutaneous lymphomas: an update. Part 2: B-cell lymphomas and related conditions","volume":"36","author":"Kempf","year":"2014","journal-title":"Am J Dermatopathol"},{"key":"10.1038\/s41379-019-0385-7_bib6","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1111\/j.1365-2133.2003.05649.x","article-title":"Bcl-2, Bcl-6 and CD10 expression in cutaneous B-cell lymphoma: further support for a follicle centre cell origin and differential diagnostic significance","volume":"149","author":"Hoefnagel","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1038\/s41379-019-0385-7_bib7","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1200\/JCO.2006.09.6396","article-title":"Reclassification of 300 primary cutaneous B-Cell lymphomas according to the new WHO-EORTC classification for cutaneous lymphomas: comparison with previous classifications and identification of prognostic markers","volume":"25","author":"Senff","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1038\/s41379-019-0385-7_bib8","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/01.pas.0000146015.22624.c7","article-title":"Clinicopathologic, immunophenotypic, and molecular cytogenetic fluorescence in situ hybridization analysis of primary and secondary cutaneous follicular lymphomas","volume":"29","author":"Kim","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-019-0385-7_bib9","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1002\/cam4.865","article-title":"Primary cutaneous B-cell lymphoma other than marginal zone: clinicopathologic analysis of 161 cases: Comparison with current classification and definition of prognostic markers","volume":"5","author":"Lucioni","year":"2016","journal-title":"Cancer Med"},{"key":"10.1038\/s41379-019-0385-7_bib10","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/cup.13399","article-title":"Primary cutaneous vs secondary cutaneous follicular lymphomas: A comparative study focused on BCL2, CD10, and t(14;18) expression","volume":"46","author":"Servitje","year":"2019","journal-title":"J Cutan Pathol"},{"key":"10.1038\/s41379-019-0385-7_bib11","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/PAS.0000000000000567","article-title":"Primary cutaneous follicle center lymphomas expressing BCL2 protein frequently harbor BCL2 gene break and may present 1p36 deletion: a study of 20 cases","volume":"40","author":"Szablewski","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-019-0385-7_bib12","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1182\/blood-2008-07-168682","article-title":"A distinctive subtype of t(14;18)-negative nodal follicular non-Hodgkin lymphoma characterized by a predominantly diffuse growth pattern and deletions in the chromosomal region 1p36","volume":"113","author":"Katzenberger","year":"2009","journal-title":"Blood"},{"key":"10.1038\/s41379-019-0385-7_bib13","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1182\/blood-2016-03-703819","article-title":"Genome-wide analysis of pediatric-type follicular lymphoma reveals low genetic complexity and recurrent alterations of TNFRSF14 gene","volume":"128","author":"Schmidt","year":"2016","journal-title":"Blood"},{"key":"10.1038\/s41379-019-0385-7_bib14","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1001\/archderm.143.12.1520","article-title":"Results of radiotherapy in 153 primary cutaneous B-Cell lymphomas classified according to the WHO-EORTC classification","volume":"143","author":"Senff","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1038\/s41379-019-0385-7_bib15","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1001\/archderm.143.9.1144","article-title":"Primary cutaneous diffuse large B-cell lymphoma, leg type: clinicopathologic features and prognostic analysis in 60 cases","volume":"143","author":"Grange","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1038\/s41379-019-0385-7_bib16","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1001\/archderm.1996.03890350042008","article-title":"Primary cutaneous large B-cell lymphomas of the legs. A distinct type of cutaneous B-cell lymphoma with an intermediate prognosis. Dutch Cutaneous Lymphoma Working Group","volume":"132","author":"Vermeer","year":"1996","journal-title":"Arch Dermatol"},{"key":"10.1038\/s41379-019-0385-7_bib17","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.1182\/blood-2004-04-1594","article-title":"Distinct types of primary cutaneous large B-cell lymphoma identified by gene expression profiling","volume":"105","author":"Hoefnagel","year":"2005","journal-title":"Blood"},{"key":"10.1038\/s41379-019-0385-7_bib18","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","article-title":"Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray","volume":"103","author":"Hans","year":"2004","journal-title":"Blood"},{"key":"10.1038\/s41379-019-0385-7_bib19","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1016\/j.jid.2017.04.010","article-title":"Identification of somatic mutations in primary cutaneous diffuse large B-cell lymphoma, leg type by massive parallel sequencing","volume":"137","author":"Mareschal","year":"2017","journal-title":"J Investig Dermatol"},{"key":"10.1038\/s41379-019-0385-7_bib20","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nature09671","article-title":"Oncogenically active MYD88 mutations in human lymphoma","volume":"470","author":"Ngo","year":"2011","journal-title":"Nature"},{"key":"10.1038\/s41379-019-0385-7_bib21","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1056\/NEJMoa1801445","article-title":"Genetics and pathogenesis of diffuse large B-cell lymphoma","volume":"378","author":"Schmitz","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1038\/s41379-019-0385-7_bib22","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1097\/PAS.0000000000001132","article-title":"High incidence and clinical significance of MYC rearrangements in primary cutaneous diffuse large B-cell lymphoma, leg type","volume":"42","author":"Schrader","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-019-0385-7_bib23","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/leu.2015.237","article-title":"Primary testicular diffuse large B-cell lymphoma displays distinct clinical and biological features for treatment failure in rituximab era: a report from the International PTL Consortium","volume":"30","author":"Deng","year":"2016","journal-title":"Leukemia"},{"key":"10.1038\/s41379-019-0385-7_bib24","doi-asserted-by":"crossref","DOI":"10.1038\/bcj.2013.28","article-title":"High prevalence of oncogenic MYD88 and CD79B mutations in diffuse large B-cell lymphomas presenting at immune-privileged sites","volume":"3","author":"Kraan","year":"2013","journal-title":"Blood Cancer J"},{"key":"10.1038\/s41379-019-0385-7_bib25","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1097\/PAS.0b013e3181f72835","article-title":"Cutaneous marginal zone lymphomas have distinctive features and include 2 subsets","volume":"34","author":"Edinger","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-019-0385-7_bib26","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.1182\/blood-2008-01-132415","article-title":"The majority of cutaneous marginal zone B-cell lymphomas expresses class-switched immunoglobulins and develops in a T-helper type 2 inflammatory environment","volume":"112","author":"van Maldegem","year":"2008","journal-title":"Blood"},{"key":"10.1038\/s41379-019-0385-7_bib27","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1097\/PAS.0000000000001363","article-title":"Class-switched primary cutaneous marginal zone lymphomas are frequently IgG4-positive and have features distinct from IgM-positive cases","volume":"43","author":"Carlsen","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-019-0385-7_bib28","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1097\/00000478-199711000-00012","article-title":"Are primary cutaneous immunocytoma and marginal zone lymphoma the same disease?","volume":"21","author":"Duncan","year":"1997","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-019-0385-7_bib29","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1038\/modpathol.2013.106","article-title":"Primary cutaneous marginal zone lymphomas with plasmacytic differentiation show frequent IgG4 expression","volume":"26","author":"Brenner","year":"2013","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-019-0385-7_bib30","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1600-0560.1997.tb01318.x","article-title":"Infection by Borrelia burgdorferi and cutaneous B-cell lymphoma","volume":"24","author":"Cerroni","year":"1997","journal-title":"J Cutan Pathol"},{"key":"10.1038\/s41379-019-0385-7_bib31","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1067\/mjd.2002.120475","article-title":"Borrelia burgdorferi-associated lymphocytoma cutis simulating a primary cutaneous large B-cell lymphoma","volume":"47","author":"Grange","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1038\/s41379-019-0385-7_bib32","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1038\/sj.leu.2403501","article-title":"Variable frequencies of MALT lymphoma-associated genetic aberrations in MALT lymphomas of different sites","volume":"18","author":"Streubel","year":"2004","journal-title":"Leukemia"},{"key":"10.1038\/s41379-019-0385-7_bib33","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1182\/blood-2002-09-2963","article-title":"T(14;18)(q32;q21) involving IGH and MALT1 is a frequent chromosomal aberration in MALT lymphoma","volume":"101","author":"Streubel","year":"2003","journal-title":"Blood"},{"key":"10.1038\/s41379-019-0385-7_bib34","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1053\/j.semdp.2016.11.007","article-title":"Cutaneous marginal zone lymphomas","volume":"34","author":"Swerdlow","year":"2017","journal-title":"Semin Diagn Pathol"},{"key":"10.1038\/s41379-019-0385-7_bib35","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/00000478-199501000-00002","article-title":"Cutaneous follicular lymphoid hyperplasia with monotypic plasma cells. A clinicopathologic study of 18 patients","volume":"19","author":"Schmid","year":"1995","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-019-0385-7_bib36","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.jid.2018.02.015","article-title":"Panel sequencing shows recurrent genetic FAS alterations in primary cutaneous marginal zone lymphoma","volume":"138","author":"Maurus","year":"2018","journal-title":"J Investig Dermatol"},{"key":"10.1038\/s41379-019-0385-7_bib37","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1097\/PAS.0b013e3182190999","article-title":"EBV-positive extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue in the posttransplant setting: a distinct type of posttransplant lymphoproliferative disorder?","volume":"35","author":"Gibson","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-019-0385-7_bib38","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1097\/PAS.0000000000001113","article-title":"Expanding the spectrum of EBV-positive marginal zone lymphomas: a lesion associated with diverse immunodeficiency settings","volume":"42","author":"Gong","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-019-0385-7_bib39","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1056\/NEJMoa1200710","article-title":"MYD88 L265P somatic mutation in Waldenstr\u00f6m's macroglobulinemia","volume":"367","author":"Treon","year":"2012","journal-title":"New Engl J Med"},{"key":"10.1038\/s41379-019-0385-7_bib40","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/PAS.0b013e3181cf8622","article-title":"EBV positive mucocutaneous ulcer\u2013a study of 26 cases associated with various sources of immunosuppression","volume":"34","author":"Dojcinov","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-019-0385-7_bib41","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1097\/PAS.0000000000000225","article-title":"Methotrexate-associated B-cell lymphoproliferative disorders presenting in the skin: a clinicopathologic and immunophenotypical study of 10 cases","volume":"38","author":"Koens","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-019-0385-7_bib42","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/pin.12745","article-title":"EBV-positive mucocutaneous ulcer arising in rheumatoid arthritis patients treated with methotrexate: Single center series of nine cases","volume":"69","author":"Satou","year":"2019","journal-title":"Pathol Int"},{"key":"10.1038\/s41379-019-0385-7_bib43","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1097\/PAS.0000000000000282","article-title":"EBV-positive mucocutaneous ulcer in organ transplant recipients: a localized indolent posttransplant lymphoproliferative disorder","volume":"38","author":"Hart","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-019-0385-7_bib44","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jdcr.2018.10.013","article-title":"EBV(+) mucocutaneous ulcers in the setting of pre-existing cutaneous T-cell lymphoproliferative disorders: a report of 2 cases","volume":"5","author":"Craddock","year":"2019","journal-title":"JAAD Case Rep"},{"key":"10.1038\/s41379-019-0385-7_bib45","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1053\/j.semdp.2016.11.003","article-title":"Cutaneous EBV-related lymphoproliferative disorders","volume":"34","author":"Gru","year":"2017","journal-title":"Semin Diagn Pathol"},{"key":"10.1038\/s41379-019-0385-7_bib46","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/00000478-200001000-00008","article-title":"Epstein-Barr virus-positive primary gastrointestinal Hodgkin's disease: association with inflammatory bowel disease and immunosuppression","volume":"24","author":"Kumar","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-019-0385-7_bib47","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1182\/blood.V89.4.1413","article-title":"Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection","volume":"89","author":"Delecluse","year":"1997","journal-title":"Blood"},{"key":"10.1038\/s41379-019-0385-7_bib48","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1097\/01.pas.0000126781.87158.e3","article-title":"Diffuse large B-cell lymphomas with plasmablastic differentiation represent a heterogeneous group of disease entities","volume":"28","author":"Colomo","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-019-0385-7_bib49","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1159\/000077324","article-title":"Cutaneous plasmablastic lymphoma in an HIV-positive male: an unrecognized cutaneous manifestation","volume":"208","author":"Hausermann","year":"2004","journal-title":"Dermatology"},{"key":"10.1038\/s41379-019-0385-7_bib50","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1046\/j.1365-2133.2003.05544.x","article-title":"Post-transplant plasmablastic lymphoma of the skin","volume":"149","author":"Nicol","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1038\/s41379-019-0385-7_bib51","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/modpathol.2010.72","article-title":"Plasmablastic lymphoma with MYC translocation: evidence for a common pathway in the generation of plasmablastic features","volume":"23","author":"Taddesse-Heath","year":"2010","journal-title":"Mod Pathol"},{"issue":"8","key":"10.1038\/s41379-019-0385-7_bib52","doi-asserted-by":"crossref","first-page":"976","DOI":"10.3324\/haematol.2016.141978","article-title":"Immune-checkpoint expression in Epstein-Barr virus positive and negative plasmablastic lymphoma: a clinical and pathological study in 82 patients","volume":"101","author":"Laurent","year":"2016","journal-title":"Haematologica"},{"key":"10.1038\/s41379-019-0385-7_bib53","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1097\/PAS.0b013e3181f3e29f","article-title":"IG\/MYC rearrangements are the main cytogenetic alteration in plasmablastic lymphomas","volume":"34","author":"Valera","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-019-0385-7_bib54","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/modpathol.2016.162","article-title":"Plasmablastic lymphoma phenotype is determined by genetic alterations in MYC and PRDM1","volume":"30","author":"Montes-Moreno","year":"2017","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-019-0385-7_bib55","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ccr.2008.01.022","article-title":"Modeling multiple myeloma by AID-dependent conditional activation of MYC","volume":"13","author":"Kuehl","year":"2008","journal-title":"Cancer Cell"},{"key":"10.1038\/s41379-019-0385-7_bib56","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/gcc.20563","article-title":"Secondary genomic rearrangements involving immunoglobulin or MYC loci show similar prevalences in hyperdiploid and nonhyperdiploid myeloma tumors","volume":"47","author":"Gabrea","year":"2008","journal-title":"Genes Chromosom Cancer"},{"key":"10.1038\/s41379-019-0385-7_bib57","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/PAS.0000000000000328","article-title":"Lymphomatoid granulomatosis\u2013a single institute experience: pathologic findings and clinical correlations","volume":"39","author":"Song","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-019-0385-7_bib58","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1097\/00000478-200109000-00001","article-title":"Cutaneous lymphomatoid granulomatosis: correlation of clinical and biologic features","volume":"25","author":"Beaty","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-019-0385-7_bib59","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1200\/JCO.2006.08.2313","article-title":"Definition, diagnosis, and management of intravascular large B-cell lymphoma: proposals and perspectives from an international consensus meeting","volume":"25","author":"Ponzoni","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1038\/s41379-019-0385-7_bib60","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1365-2141.2004.05177.x","article-title":"Intravascular lymphoma: clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the \u2018cutaneous variant\u2018","volume":"127","author":"Ferreri","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1038\/s41379-019-0385-7_bib61","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1097\/00000478-199707000-00016","article-title":"Intravascular large cell lymphoma coexisting within hemangiomas of the skin","volume":"21","author":"Rubin","year":"1997","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-019-0385-7_bib62","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1046\/j.1365-2133.1997.18621932.x","article-title":"Generalized telangiectasia as the major manifestation of angiotropic (intravascular) lymphoma","volume":"137","author":"Ozguroglu","year":"1997","journal-title":"Br J Dermatol"},{"key":"10.1038\/s41379-019-0385-7_bib63","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1182\/blood-2017-04-737445","article-title":"Intravascular large B-cell lymphoma: a chameleon with multiple faces and many masks","volume":"132","author":"Ponzoni","year":"2018","journal-title":"Blood"},{"key":"10.1038\/s41379-019-0385-7_bib64","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/his.13870","article-title":"A study of PD-L1 expression in intravascular large B cell lymphoma: correlation with clinical and pathological features","volume":"75","author":"Gupta","year":"2019","journal-title":"Histopathology"},{"key":"10.1038\/s41379-019-0385-7_bib65","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1182\/blood-2017-12-822817","article-title":"High prevalence of MYD88 and CD79B mutations in intravascular large B-cell lymphoma","volume":"131","author":"Schrader","year":"2018","journal-title":"Blood"},{"key":"10.1038\/s41379-019-0385-7_bib66","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/0190-9622(91)70302-I","article-title":"Lymphoblastic lymphoma presenting in cutaneous sites. A clinicopathologic analysis of six cases","volume":"25","author":"Sander","year":"1991","journal-title":"J Am Acad Dermatol"},{"key":"10.1038\/s41379-019-0385-7_bib67","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1600-0560.1999.tb01861.x","article-title":"Cutaneous involvement in lymphoblastic lymphoma","volume":"26","author":"Chimenti","year":"1999","journal-title":"J Cutan Pathol"},{"key":"10.1038\/s41379-019-0385-7_bib68","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1097\/00000478-200011000-00003","article-title":"Precursor B-cell lymphoblastic lymphoma: a predominantly extranodal tumor with low propensity for leukemic involvement","volume":"24","author":"Lin","year":"2000","journal-title":"Am J Surg Pathol"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41379-019-0385-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41379-019-0385-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222007220?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222007220?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41379-019-0385-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T00:38:36Z","timestamp":1760229516000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222007220"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":68,"alternative-id":["S0893395222007220"],"URL":"https:\/\/doi.org\/10.1038\/s41379-019-0385-7","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Navigating the cutaneous B-cell lymphomas: avoiding the rocky shoals","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/s41379-019-0385-7","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}